Soleno Therapeutics, Inc. generated $190.4M in revenue in fiscal year 2025. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Soleno Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SLNO Revenue by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
SLNO Revenue by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Soleno Therapeutics, Inc. financials
Frequently Asked Questions
Soleno Therapeutics, Inc. generated $190.4M in revenue in fiscal year 2025.
Across the 13 fiscal years this page covers, Soleno Therapeutics, Inc. (SLNO) revenue went from $3.0M in fiscal year 2013 to $190.4M in fiscal year 2025.
Soleno Therapeutics, Inc. (SLNO) reported $94.6M in revenue in Q1 2026.
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Soleno Therapeutics, Inc. (SLNO) reported on that line in every period on record.